Maintenance therapy for patients with advanced non-small cell lung cancer: fact or myth? M. Dediu Editorial 21 April 2011 Pages: 1 - 2
Large cell carcinoma of the lung – a vanishing entity? H. H. Popper Short review 21 April 2011 Pages: 4 - 9
VATS lobectomy – new era in surgical treatment of NSCLC W. Zurek Short review 21 April 2011 Pages: 10 - 15
Adjuvant chemotherapy in stage IB NSCLC: implication of the new TNM staging system M. Dediu Short review 21 April 2011 Pages: 16 - 18
Maintenance therapy for patients with advanced non-small cell lung cancer: Who to treat and how to treat? S. I. RothschildO. Gautschi Review 21 April 2011 Pages: 19 - 22
Targeted therapies in advanced non-small cell lung cancer: success or failure? E. SzutowiczK. KonopaJ. Jassem Short Review 21 April 2011 Pages: 23 - 26
Mitomycin C in combination with vinorelbine or cisplatin and erythropoietin in pretreated patients with in field relapse after radiation therapy of non-small cell lung cancer: a phase II trial of the AIO I. StengerC. TomalaF. Griesinger Original report 21 April 2011 Pages: 31 - 37
STAT signalling in malignant mesothelioma: Is there a regulatory effect of microRNAs? L. ArztH. KothmaierH. H. Popper Original report 21 April 2011 Pages: 38 - 42
Comorbidity – an important domain in elderly cancer patients' assessment R. SimanekJ. WalczukK. Geissler Short review 21 April 2011 Pages: 43 - 49
Associations of serum uric acid and gamma-glutamyltransferase with cancer in the Vorarlberg Health Monitoring and Promotion Programme (VHM&PP) – a short review M. EdlingerG. NagelH. Ulmer Short review 21 April 2011 Pages: 50 - 54